Aliskiren and valsartan in combination is a promising therapy for hypertensive renal injury in rats.
CONCLUSION: These results suggest that therapies aimed at different targets within the RAAS may have additional effects in attenuating structural injury in experimental hypertensive nephropathy.
PMID: 29172824 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Hypertension - Category: Cardiology Authors: Abdel Kawy HS Tags: Clin Exp Hypertens Source Type: research